Recent Finacing
Recent Raise
Replay develops genome‑writing and delivery platforms—uCell hypoimmunogenic cells, synHSV high‑payload HSV vectors, and proprietary genome‑writing tools—and operates a hub‑and‑spoke model licensing tech to product companies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
